Picture of Trilogy International Partners logo

TRL.H — Trilogy International Partners News Story

0.000.00%
ca flag iconLast trade - 00:00
TelecomsSpeculativeMicro CapContrarian

Brief: Trimel files Natesto with Health Canada

Jan 26 (Reuters) - Trimel Pharmaceuticals Corp  TRL.TO : 
 * Announces filing of Natesto(TM) with Health Canada 
 * Filed new drug submission with Health Canada for natesto nasal gel for 
   replacement therapy in men 
 * Commercial rights to natesto in United States and Mexico have been licensed 
   by Trimel to affiliate of Endo International PLC 
 * Endo intends to launch the product in the U.S., through its Endo 
   Pharmaceuticals subsidiary, in this first quarter of 2015 
 
* Source text for Eikon  ID:nMKW90mfFa  
 
* Further company coverage  TRL.TO  ((Bengaluru Newsroom; +1 646 223 8780))

Recent news on Trilogy International Partners

See all news